Our results suggest a model in which high TMEM44‐AS1 expression sponges miR‐2355‐5p, resulting in the upregulation of PPP1R13L, together with subsequent P53 pathway inhibition, with the consequent reduction in the rates of apoptosis and reduced 5‐FU sensitivity in GC. The gene discussed is TP53; the disease is gastric cancer.